BRANFORD, Conn., Feb. 10 /PRNewswire-FirstCall/ -- CuraGen Corporation announced today that Timothy M. Shannon, M.D., Executive Vice President of Research and Development and Chief Medical Officer, will present at the BIO CEO & Investor Conference on Tuesday, February 14, 2006, at 2:00 p.m. Eastern time.
Access to a live webcast of the presentation will be available at http://www.curagen.com. A replay of the webcast will be accessible beginning one hour after the presentation and available on the Company's website until March 14, 2006.
About CuraGen
CuraGen Corporation is a biopharmaceutical company dedicated to improving the lives of patients by developing a pipeline of novel protein, antibody, and small molecule therapeutics in the areas of oncology, inflammatory diseases, and diabetes. CuraGen has established broad development alliances with Abgenix, TopoTarget, and Bayer, and its experienced preclinical and clinical teams are advancing CuraGen's pipeline of products for unmet medical needs. CuraGen is headquartered in Branford, Connecticut. For additional information please visit http://www.curagen.com.
CuraGen Contact: Glenn Schulman, Pharm.D. Assistant Director of Investor Relations gschulman@curagen.com (888) 436-6642
CuraGen CorporationCONTACT: Glenn Schulman, Assistant Director of Investor Relations ofCuraGen Corporation, +1-888-436-6642
Web site: http://www.curagen.com//
